- Home
- ERAS vs ADV Comparison
ERAS vs ADV Comparison
Compare ERAS & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- ADV
- Stock Information
- Founded
- ERAS 2018
- ADV 1987
- Country
- ERAS United States
- ADV United States
- Employees
- ERAS N/A
- ADV N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- ADV Business Services
- Sector
- ERAS Health Care
- ADV Consumer Discretionary
- Exchange
- ERAS Nasdaq
- ADV Nasdaq
- Market Cap
- ERAS 396.6M
- ADV 420.4M
- IPO Year
- ERAS 2021
- ADV N/A
- Fundamental
- Price
- ERAS $1.39
- ADV $1.47
- Analyst Decision
- ERAS Strong Buy
- ADV Strong Buy
- Analyst Count
- ERAS 6
- ADV 1
- Target Price
- ERAS $4.83
- ADV $3.50
- AVG Volume (30 Days)
- ERAS 1.4M
- ADV 360.6K
- Earning Date
- ERAS 05-20-2025
- ADV 05-12-2025
- Dividend Yield
- ERAS N/A
- ADV N/A
- EPS Growth
- ERAS N/A
- ADV N/A
- EPS
- ERAS N/A
- ADV N/A
- Revenue
- ERAS N/A
- ADV $3,566,324,000.00
- Revenue This Year
- ERAS N/A
- ADV N/A
- Revenue Next Year
- ERAS N/A
- ADV N/A
- P/E Ratio
- ERAS N/A
- ADV N/A
- Revenue Growth
- ERAS N/A
- ADV N/A
- 52 Week Low
- ERAS $1.01
- ADV $1.11
- 52 Week High
- ERAS $3.45
- ADV $4.68
- Technical
- Relative Strength Index (RSI)
- ERAS 51.46
- ADV 55.91
- Support Level
- ERAS $1.37
- ADV $1.27
- Resistance Level
- ERAS $1.61
- ADV $1.41
- Average True Range (ATR)
- ERAS 0.14
- ADV 0.08
- MACD
- ERAS 0.00
- ADV 0.04
- Stochastic Oscillator
- ERAS 45.68
- ADV 96.36
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.